• Issue

    Hepatology Research: Volume 50, Issue 3

    269-404
    March 2020
Previous Issue|Next Issue
Export Citation(s)Download PDF(s)

Issue Information

Free Access

Issue Information

  • Pages: 269-270
  • First Published: 06 March 2020

Review Article

Discordance of hepatitis B vaccination policies for healthcare workers between the USA, the UK, and Germany

Haruki Komatsu,  Paul Klenerman,  Robert Thimme, 
  • Pages: 272-282
  • First Published: 17 December 2019

Viral hepatitis

Anti-viral effects of interferon-λ3 on hepatitis B virus infection in cell culture

Norie Yamada,  Asako Murayama,  Masaaki Shiina,  Hussein Hassan Aly,  Masashi Iwamoto,  Senko Tsukuda,  Koichi Watashi,  Tomohisa Tanaka,  Kohji Moriishi,  Hironori Nishitsuji,  Masaya Sugiyama,  Masashi Mizokami,  Kunitada Shimotohno,  Masamichi Muramatsu,  Kazumoto Murata,  Takanobu Kato, 
  • Pages: 283-291
  • First Published: 22 November 2019

Molecular signature of hepatitis B virus regulation by interferon-γ in primary human hepatocytes

Takuto Nosaka,  Tatsushi Naito,  Hidetaka Matsuda,  Masahiro Ohtani,  Katsushi Hiramatsu,  Tomoyuki Nemoto,  Tsutomu Nishizawa,  Hiroaki Okamoto,  Yasunari Nakamoto, 
  • Pages: 292-302
  • First Published: 16 November 2019

Favorable outcome of retreatment by direct-acting antivirals for hepatitis C patients with daclatasvir plus asunaprevir combination therapy failure

Hiroki Tojima,  Satoru Kakizaki,  Satoshi Takakusagi,  Takashi Hoshino,  Atsushi Naganuma,  Tamon Nagashima,  Masashi Namikawa,  Takashi Ueno,  Yasushi Shimada,  Takeshi Hatanaka,  Daichi Takizawa,  Hirotaka Arai,  Ken Sato,  Hitoshi Takagi,  Toshio Uraoka, 
  • Pages: 303-312
  • First Published: 21 November 2019

Hepatocellular carcinoma occurrence does not differ between interferon-based and interferon-free treatment with liver histological assessment

Yuki Tahata,  Ryotaro Sakamori,  Ayako Urabe,  Ryoko Yamada,  Kazuyoshi Ohkawa,  Naoki Hiramatsu,  Hideki Hagiwara,  Masahide Oshita,  Taizo Hijioka,  Shinji Tamura,  Yasuharu Imai,  Takahiro Kodama,  Hayato Hikita,  Tomohide Tatsumi,  Tetsuo Takehara, 
  • Pages: 313-320
  • First Published: 20 November 2019

Autoimmune Liver Disease

Evaluation of muscarinic acetylcholine receptor type 3 gene polymorphisms in patients with primary biliary cholangitis and primary sclerosing cholangitis

Lena Maria Greverath,  Elise Leicht,  Nina Wald de Chamorro,  Anne-Christin Beatrice Wilde,  Lara Marleen Steinhagen,  Charlotte Lieb,  Moritz Schmelzle,  Sascha Chopra,  Oren Shibolet,  Janett Fischer,  Thomas Berg,  Frank Tacke,  Tobias Müller, 
  • Pages: 321-329
  • First Published: 20 November 2019

Cirrhosis and Portal Hypertension

Clinical utility of the Liver Frailty Index for predicting muscle atrophy in chronic liver disease patients with hepatocellular carcinoma

Keisuke Hirota,  Takumi Kawaguchi,  Shunji Koya,  Ayu Nagamatsu,  Manabu Tomita,  Ryuki Hashida,  Dan Nakano,  Takashi Niizeki,  Hiroo Matsuse,  Naoto Shiba,  Takuji Torimura, 
  • Pages: 330-341
  • First Published: 12 November 2019
Open Access

Inflammation, etiologies and Model for End-stage Liver Disease score: What makes liver disease patients susceptible to developing colorectal neoplasia?

Amelie S. Troschel,  Alexander Miks,  Anna Hüsing-Kabar,  Hauke S. Heinzow,  Hartmut H. Schmidt,  Fabian M. Troschel,  Iyad Kabar, 
  • Pages: 342-352
  • First Published: 05 December 2019

Hepatocellular Carcinoma and other malignacy

Activation of extracellular signal-regulated kinase is associated with hepatocellular carcinoma with aggressive phenotypes

Takuya Minagawa,  Ken Yamazaki,  Yohei Masugi,  Hanako Tsujikawa,  Hidenori Ojima,  Taizo Hibi,  Yuta Abe,  Hiroshi Yagi,  Minoru Kitago,  Masahiro Shinoda,  Osamu Itano,  Yuko Kitagawa,  Michiie Sakamoto, 
  • Pages: 353-364
  • First Published: 08 November 2019

Hypovascular hepatic nodules as a predictive factor for transcatheter arterial chemoembolization refractoriness in hepatocellular carcinoma

Kazuki Maesaka,  Ryotaro Sakamori,  Ryoko Yamada,  Yuki Tahata,  Ayako Urabe,  Minoru Shigekawa,  Takahiro Kodama,  Hayato Hikita,  Tomohide Tatsumi,  Tetsuo Takehara, 
  • Pages: 365-373
  • First Published: 29 October 2019

Favorable radiological antitumor response at 2 weeks after starting lenvatinib for patients with advanced hepatocellular carcinoma

Teiji Kuzuya,  Masatoshi Ishigami,  Takanori Ito,  Yoji Ishizu,  Takashi Honda,  Tetsuya Ishikawa,  Mitsuhiro Fujishiro, 
  • Pages: 374-381
  • First Published: 12 November 2019

Analyses of objective response rate, progression-free survival, and adverse events in hepatocellular carcinoma patients treated with lenvatinib: A multicenter retrospective study

Takeshi Hatanaka,  Satoru Kakizaki,  Tamon Nagashima,  Masashi Namikawa,  Hiroki Tojima,  Yasushi Shimada,  Daichi Takizawa,  Atsushi Naganuma,  Hirotaka Arai,  Ken Sato,  Norifumi Harimoto,  Ken Shirabe,  Toshio Uraoka, 
  • Pages: 382-395
  • First Published: 23 November 2019

Short Communication

Open Access

Zinc deficiency in patients with chronic liver disease in Japan

Itaru Ozeki,  Tomohiro Arakawa,  Hirokazu Suii,  Ryoji Tatsumi,  Masakatsu Yamaguchi,  Tomoaki Nakajima,  Yasuaki Kuwata,  Joji Toyota, 
  • Pages: 396-401
  • First Published: 29 November 2019

Letter to the Editor

Early changes in tubular dysfunction markers and phosphorus metabolism regulators as a result of switching from entecavir to tenofovir alafenamide fumarate nucleoside analog therapy for chronic hepatitis B patients

Kazuo Notsumata,  Yoshimoto Nomura,  Akihiro Tanaka,  Teruyuki Ueda,  Taku Sanada,  Hiroyuki Watanabe,  Daishu Toya, 
  • Pages: 402-404
  • First Published: 06 November 2019